Insider trade

Officer sold ~$23K of NTLA shares in the open market

Traded Oct 2, 2026 · Filed Oct 7, 2026

~$23K
Approx. value · 1,864 sh @ $12.43: 65K
Holds after · shares reported: +0.9%
Since filing · from the first close after the filing, $12.26 → $12.37 on Oct 6, S&P 500 +1.2%

Why it stands out

Intellia Therapeutics's VP, Chief Accounting Officer sold $23K of Intellia Therapeutics shares. The filing references tax withholding.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Officer<$25KPre-arranged plan referenced

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$23,170

Shares × reported transaction price

Timing vs results

57 days after results of Aug 6, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

Footnote references tax withholding

Only flagged when a footnote says so; never inferred

Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on October 1, 2026, and does not represent a volitional trade by the Reporting Person.

Planned, from payFiled 2d ago